These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27379855)

  • 1. [Drug Treatment of Chronic Venous Diesease].
    Pavlović MD
    Wien Med Wochenschr; 2016 Jun; 166(9-10):312-9. PubMed ID: 27379855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease.
    Nicolaides AN
    Adv Ther; 2020 Feb; 37(Suppl 1):1-5. PubMed ID: 31970659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF).
    Bush R; Comerota A; Meissner M; Raffetto JD; Hahn SR; Freeman K
    Phlebology; 2017 Apr; 32(1_suppl):3-19. PubMed ID: 28211296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
    Ulloa JH
    Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical treatment of chronic venous disease: evolution or involution?].
    Agus GB
    Minerva Cardioangiol; 2011 Jun; 59(3):285-98. PubMed ID: 21516076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment in patients with C4, C5 and C6 venous disease.
    Gohel MS; Davies AH
    Phlebology; 2010 Oct; 25 Suppl 1():35-41. PubMed ID: 20870818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approach to chronic venous insufficiency - clinical benefits of red-vine-leaf-extract AS 195 (Antistax
    Stücker M; Rabe E; Meyer K; Ottillinger B; Schütt T
    Pharmazie; 2019 Apr; 74(4):193-200. PubMed ID: 30940301
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency.
    Lichota A; Gwozdzinski L; Gwozdzinski K
    Eur J Med Chem; 2019 Aug; 176():68-91. PubMed ID: 31096120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
    Gloviczki P; Comerota AJ; Dalsing MC; Eklof BG; Gillespie DL; Gloviczki ML; Lohr JM; McLafferty RB; Meissner MH; Murad MH; Padberg FT; Pappas PJ; Passman MA; Raffetto JD; Vasquez MA; Wakefield TW; ;
    J Vasc Surg; 2011 May; 53(5 Suppl):2S-48S. PubMed ID: 21536172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.
    Gianesini S; De Luca L; Feodor T; Taha W; Bozkurt K; Lurie F
    Adv Ther; 2023 Dec; 40(12):5137-5154. PubMed ID: 37768506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micronized purified flavonoid fraction and the treatment of chronic venous insufficiency: microcirculatory mechanisms.
    Smith PD
    Microcirculation; 2000; 7(6 Pt 2):S35-40. PubMed ID: 11151970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease.
    Allegra C; Antignani PL
    Int Angiol; 2014 Oct; 33(5):407-18. PubMed ID: 24566500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects of deep venous varicose insufficiency].
    Petter O
    Phlebologie; 1992; 45(3):247-53; discussion 253-4. PubMed ID: 1470647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium dobesilate and oxerutin: effectiveness of combination therapy.
    Akbulut B
    Phlebology; 2010 Apr; 25(2):66-71. PubMed ID: 20348452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency.
    Rabe E; Ballarini S; Lehr L;
    Phlebology; 2016 May; 31(4):264-74. PubMed ID: 25991692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CVD: a condition of underestimated severity.
    Lattimer CR
    Int Angiol; 2014 Jun; 33(3):222-8. PubMed ID: 24732585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease--a prospective study.
    Shoab SS; Porter J; Scurr JH; Coleridge-Smith PD
    Eur J Vasc Endovasc Surg; 1999 Apr; 17(4):313-8. PubMed ID: 10204053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
    Flota-Cervera F; Flota-Ruiz C; Treviño C; Berber A
    Angiology; 2008; 59(3):352-6. PubMed ID: 18388097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical existence of isolated non-thrombotic insufficiency of the conductive veins of the leg].
    Petter O
    Z Gesamte Inn Med; 1990 Feb; 45(4):93-6. PubMed ID: 2360364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plethysmographic confirmation of the beneficial effect of calcium dobesilate in primary varicose veins.
    Androulakis G; Panoysis PA
    Angiology; 1989 Jan; 40(1):1-4. PubMed ID: 2642669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.